youtube_live
Q3 2026 earnings • released • EPS beat +4.92% • Revenue miss -5.38%
See resultschevron_right
KLBF:IDX
PT Kalbe Farma Tbk.
IDRÂ 715.00
arrow_downward
-0.69%(-5.00) 1D
Nov 3, 4:06:39 PM GMT+7 · IDR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KLBF...
Open
IDRÂ 720
High
IDRÂ 735
Low
IDRÂ 715
Mkt. cap
33.47T
Avg. vol.
54.28M
Volume
54.99M
Dividend
2.80%
Quarterly dividend
IDRÂ 5
Ex-dividend date
Jun 4, 2026
P/E ratio
8.99
52-wk high
IDRÂ 1,320
52-wk low
IDRÂ 630
EPS
IDRÂ 80
Shares outstanding
46.81B
No. of employees
13K
Open
IDRÂ 720
High
IDRÂ 735
Low
IDRÂ 715
Mkt. cap
33.47T
Avg. vol.
54.28M
Volume
54.99M
Dividend
2.80%
Quarterly dividend
IDRÂ 5
Ex-dividend date
Jun 4, 2026
P/E ratio
8.99
52-wk high
IDRÂ 1,320
52-wk low
IDRÂ 630
EPS
IDRÂ 80
Shares outstanding
46.81B
No. of employees
13K
News stories
From web sources and news partners
AP News
·
1 hour ago
US job postings jumped sharply in September, potentially a good sign for anyone seeking employment
Yahoo Finance
·
40 minutes ago
Netflix Trades at a Discount to the S&P 500's Valuation. Is It Deserved?
Bloomberg.com
·
2 hours ago
Goldman’s Molavi Says 60% of S&P 500 Is in Bear Market Territory
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About PT Kalbe Farma Tbk.